aTyr Pharma Statistics

Total Valuation

aTyr Pharma has a market cap or net worth of $251.64 million. The enterprise value is $186.83 million.

Market Cap	251.64M
Enterprise Value	186.83M

Important Dates

The next estimated earnings date is Thursday, November 7, 2024.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

aTyr Pharma has 75.80 million shares outstanding. The number of shares has increased by 65.08% in one year.

Shares Outstanding	75.80M
Shares Change (YoY)	+65.08%
Shares Change (QoQ)	+9.39%
Owned by Insiders (%)	2.62%
Owned by Institutions (%)	63.50%
Float	68.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.08
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	317.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.63, with a Debt / Equity ratio of 0.17.

Current Ratio	7.63
Quick Ratio	6.77
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -61.76% and return on invested capital (ROIC) is -36.06%.

Return on Equity (ROE)	-61.76%
Return on Assets (ROA)	-32.74%
Return on Capital (ROIC)	-36.06%
Revenue Per Employee	$9,966
Profits Per Employee	-$981,305
Employee Count	59
Asset Turnover	0.00
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +176.67% in the last 52 weeks. The beta is 1.21, so aTyr Pharma's price volatility has been higher than the market average.

Beta (5Y)	1.21
52-Week Price Change	+176.67%
50-Day Moving Average	2.14
200-Day Moving Average	1.86
Relative Strength Index (RSI)	81.98
Average Volume (20 Days)	1,574,280

Short Selling Information

The latest short interest is 1.07 million, so 1.41% of the outstanding shares have been sold short.

Short Interest	1.07M
Short Previous Month	1.36M
Short % of Shares Out	1.41%
Short % of Float	1.55%
Short Ratio (days to cover)	1.47

Income Statement

In the last 12 months, aTyr Pharma had revenue of $588,000 and -$57.90 million in losses. Loss per share was -$0.91.

Revenue	588,000
Gross Profit	-49.82M
Operating Income	-62.53M
Pretax Income	-53.93M
Net Income	-57.90M
EBITDA	-61.82M
EBIT	-62.53M
Loss Per Share	-$0.91

Full Income Statement

Balance Sheet

The company has $78.48 million in cash and $13.85 million in debt, giving a net cash position of $64.63 million or $0.85 per share.

Cash & Cash Equivalents	78.48M
Total Debt	13.85M
Net Cash	64.63M
Net Cash Per Share	$0.85
Equity (Book Value)	81.42M
Book Value Per Share	1.08
Working Capital	78.46M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$63.45 million and capital expenditures -$599,000, giving a free cash flow of -$64.05 million.

Operating Cash Flow	-63.45M
Capital Expenditures	-599,000
Free Cash Flow	-64.05M
FCF Per Share	-$0.85

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-10,633.50%
Pretax Margin	-9,846.26%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	-9,860.88%

Dividends & Yields

aTyr Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-65.08%
Shareholder Yield	-65.08%
Earnings Yield	-23.01%
FCF Yield	-25.45%

Analyst Forecast

The average price target for aTyr Pharma is $19.25, which is 479.82% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$19.25
Price Target Difference	479.82%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	315.62%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on July 1, 2019. It was a reverse split with a ratio of 0.0714285:1.

Last Split Date	Jul 1, 2019
Split Type	Reverse
Split Ratio	0.0714285:1

Scores

aTyr Pharma has an Altman Z-Score of -5.2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.2
Piotroski F-Score	n/a